|
|
|
|
|
|
|
|
|
|
Previous: GUILFORD PHARMACEUTICALS INC, 10-Q, EX-10.62, 2000-11-14 |
Next: NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, 10QSB, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 23,051
<SECURITIES> 94,079
<RECEIVABLES> 1,576
<ALLOWANCES> 0
<INVENTORY> 1,776
<CURRENT-ASSETS> 101,889
<PP&E> 29,663
<DEPRECIATION> 15,587
<TOTAL-ASSETS> 136,826
<CURRENT-LIABILITIES> 10,494
<BONDS> 5,491
0
0
<COMMON> 238
<OTHER-SE> 120,603
<TOTAL-LIABILITY-AND-EQUITY> 136,826
<SALES> 1,492
<TOTAL-REVENUES> 8,536
<CGS> 1,252
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 44,143
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 410
<INCOME-PRETAX> (31,239)
<INCOME-TAX> 0
<INCOME-CONTINUING> (31,239)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (31,239)
<EPS-BASIC> (1.33)
<EPS-DILUTED> (1.33)
</TABLE>
|
|